RSRegine Schneider-Stock

Regine Schneider-Stock

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Regine Schneider-Stock has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Trichostatin A causes p53 to switch oxidative‐damaged colorectal cancer cells from cell cycle arrest into apoptosis

    by C. Habold, A. Poehlmann, K. Bajbouj, R. Hartig, K.S. Korkmaz, A. Roessner, R. Schneider‐Stock

    Many studies aim at improving therapeutic efficacy by combining strategies with oxidative stress‐inducing drugs and histone deacetylase (HDAC) inhibitors in colorectal cancer. As p53 and p21WAF1 are essential in oxidative stress‐induced DNA damage, we investigated epigenetic regulation of p21WAF1 promoter. Firstly, HCT116 p53+/+ and p53−/− colorectal cancer cells were treated with H2O2 for 6 hrs and 24 hrs (early/late response). Chromatin immunoprecipitation revealed transcriptional transactivation of p21WAF1 in HCT116 p53+/+ cells as shown by increased binding of p53 and acetylated H4 around two p21WAF1 promoter sites, the responsible element (RE) and the Sp1 site, while both proteins bound preferentially on the RE. Interestingly, H3 was not involved, suggesting H4‐specific transactivation of the p21WAF1 promoter. H2O2 addition resulted in G2/M arrest of both HCT116 cell lines without significant cell death. To investigate whether a HDAC inhibitor strengthens G2/M arrest, we pretreated cells with Trichostatin A (TSA). In HCT116 p53+/+ cells, we found (i) remarkably increased acetylated H4 around both p21WAF1 promoter regions, especially at the Sp1 site; (ii) increased acetylation of p53 at lysines 320 and 382;(iii) displacement of HDAC1 from the Sp1 site, thus inhibiting its repression effect and increasing p53 binding.p53 seems to trigger H4‐acetylation around the p21WAF1 promoter because there was nearly no H4 acetylation in HCT116 p53−/− cells. For the first time we show that there is a time‐dependent TSA mode of action with increased p53‐dependent histone H4 acetylation at the p21WAF1 promoter in early response, and decreased acetylation in late response. Reduced p53‐triggered transactivation of p21WAF1 in late response allows cells to re‐enter cell cycle, and TSA causes p53 to simultaneously induce apoptosis.


  • Close localization of DAP‐kinase positive tumour‐associated macrophages and apoptotic colorectal cancer cells

    by R Schneider‐Stock, D Kuester, O Ullrich, F Mittag, C Habold, C Boltze, B Peters, S Krueger, C Hintze, F Meyer, et al.

    The death‐associated protein kinase (DAP‐kinase) is a cytoskeleton‐associated protein crucially involved in the induction of early apoptotic pathways. Aberrant hypermethylation of the DAP‐kinase promoter plays a major role in tumorigenesis. We aimed to investigate the inactivation of DAP‐kinase and its association with apoptotic cell death in 94 colorectal carcinomas. DAP‐kinase promoter hypermethylation and mRNA expression were investigated using methylation‐specific PCR and real‐time RT‐PCR, respectively. The expression of DAP‐kinase, Fas, and Fas‐ligand (FasL) proteins was studied by immunohistochemistry and immunofluorescence. Apoptosis of tumour cells was investigated using the TUNEL assay. DAP‐kinase was expressed in tumour cells and tumour‐invading macrophages and was closely associated with high numbers of apoptotic tumour cells. DAP‐kinase expression co‐localized with FasL overexpression in tumour‐associated macrophages, and aberrant promoter hypermethylation was verified in more than 50% of carcinomas. There was a tendency for proximal tumours to show DAP‐kinase promoter methylation more frequently (p = 0.07). Promoter methylation resulted in a decrease or loss of DAP‐kinase protein expression in tumour cells and tumour‐associated macrophages. Simultaneously, a decreased apoptotic count and loss of Fas/FasL expression was observed in tumour cells. Our study is the first to demonstrate DAP‐kinase expression in invading tumour‐associated macrophages in colorectal cancer. The presence of similar expression levels of DAP‐kinase in tumour cells and associated macrophages, and their dependence on the promoter methylation status of the tumour cells, suggests cross talk between these cell types during apoptotic cell death. Copyright © 2006 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.


  • Methyltransferases in apoptosis and cancer

    by Regine Schneider-Stock, Albert Roessner, Oliver Ullrich


  • Elevated telomerase activity, c‐MYC‐, and hTERT mRNA expression: association with tumour progression in malignant lipomatous tumours

    by Regine Schneider‐Stock, Carsten Boltze, Viola Jäger, Jörg Epplen, Olfert Landt, Brigitte Peters, Janusz Rys, Albert Roessner

    The role of telomerase activity in tumour progression of liposarcomas is not well understood. Therefore, we investigated 72 liposarcomas of different histological subtypes for an association between telomeric lengths and telomerase activity, and assessed the association between the catalytic subunit human telomerase reverse transcriptase (hTERT) and its activator c‐MYC. Telomeric repeat fragment lengths were determined using radioactive DNA–fingerprint analysis with the telomere‐specific probe (TTAGGG)3, whereas telomerase activity was ascertained using the non‐radioactive TRAP‐assay. To evaluate the expression of hTERT and c‐MYC, we applied real‐time RT‐PCR using a LightCycler. Eight tumours were investigated by microdissection. The MIB1‐proliferation index and hTERT and c‐MYC protein expression were determined immunohistochemically. Genetic alterations showed a high degree of tumour specificity. Highly malignant myxoid/round cell liposarcomas showed the longest telomeres, the strongest telomerase activity, and the highest hTERT and c‐MYC expression levels compared with the pure myxoid variants (p < 0.001), which are of low malignancy. Pleomorphic liposarcoma was characterized by zero or low hTERT and c‐MYC expression and telomerase activity, but long telomeres, underlining their different pathogenetic pathway. Elevated gene expression was accompanied by protein immunopositivity. MIB1‐proliferation index did not correlate with other molecular markers. We conclude that hTERT and c‐MYC expression are associated with telomerase activity in liposarcomas. Elevated hTERT and c‐MYC expression as well as high telomerase activity play a role in the tumour progression of this sarcoma type. Nevertheless, each histological subtype of liposarcomas is defined by a specific molecular pattern. Telomerase activation is the most common pathway in liposarcomas maintaining telomeric length. Copyright © 2003 John Wiley & Sons, Ltd.


  • Significance of loss of heterozygosity of the RB1 gene during tumour progression in well‐differentiated liposarcomas

    by Regine Schneider‐Stock, Carsten Boltze, Viola Jaeger, Marcus Stumm, Christiane Seiler, Janusz Rys, Karin Schütze, Albert Roessner

    Tumour progression can be investigated in liposarcomas showing a transition from a low‐grade well‐differentiated (WD) to a high‐grade dedifferentiated (DD) variant. As RB1 gene alterations are common defects in sarcomas, this study examined the frequency of RB1 loss of heterozygosity (LOH) in a group of 14 well‐differentiated liposarcomas (WDLs) and 17 well‐differentiated/dedifferentiated liposarcomas (WD/DDLs), using a microdissection approach (PALM laser pressure catapulting) that allows the two histological components to be separated for polymerase chain reaction (PCR) analysis. In addition, RB1 protein expression and the Mib1 proliferation index were determined by immunohistochemistry and interphase FISH was performed with an RB1 probe at 13q14. By the use of four intragenic polymorphic RB1 markers (introns 1, 17, 20, and 25) for PCR, allelic losses were found only in the DD parts, but never in the pure WDLs or in the WD components of the WD/DDLs investigated. Furthermore, DD areas characterized by a heterogeneous RB1 protein expression pattern (35–65% immunopositivity), as compared with 90–100% RB1 positivity in WD areas, showed a marked increase in Mib1 proliferation index (19.6% versus 1.8% in WD areas; pin situ hybridization (FISH) detected a higher RB1‐LOH rate in the DD components of WD/DDLs. Considering the different detection sensitivities of the three methodologies, it is concluded that loss of RB1 function already begins in the WDL, and that the tumour cell population with RB1‐LOH starts prevailing in the tumour mass during progression of a WDL. Copyright © 2002 John Wiley & Sons, Ltd.


  • Open Access

    High telomerase activity and high HTRT mRNA expression differentiate pure myxoid and myxoid/round-cell liposarcomas

    by Regine Schneider-Stock, Viola Jaeger, Janusz Rys, Jörg T. Epplen, Albert Roessner

    Molecular markers characterizing the transition of a myxoid to a more round‐cell liposarcoma have not been described. To examine whether telomerase activity, hTRT and hTR mRNA expression were associated with tumor progression in myxoid liposarcoma, we investigated a total of 28 myxoid liposarcomas (13 pure myxoid tumors, 14 mixed‐type tumors, and 1 pure round‐cell variant) from 19 patients. Telomerase activity was detected by using the fluorescent PCR‐based TRAP‐assay. Expression of hTRT and hTR mRNAs was determined by the semi‐quantitative RT‐PCR. On the basis of only one tumor sample per patient, telomerase activity was found in 9 of 9 myxoid/round‐cell liposarcomas and in 3 of 10 pure myxoid tumors. Elevated hTRT expression was found in 13 of 17 liposarcomas. All telomerase‐positive tumors showed hTRT expression, whereas there were 3 cases showing hTRT expression without telomerase activity. HTR mRNA expression was elevated in all 19 liposarcomas. Thus, only the levels of telomerase activity and of hTRT mRNA expression differentiated pure myxoid liposarcoma and myxoid/round‐cell liposarcoma (p < 0.003 and p = 0.029, respectively). We believe that high levels of telomerase activity and of hTRT expression are associated with tumor progression from low‐grade pure myxoid to higher‐grade malignant round‐cell liposarcoma, and may consequently represent a useful prognostic marker for this histological sub‐type of soft‐tissue tumors. Int. J. Cancer (Pred. Oncol.) 89:63–68, 2000.